News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Rainbow BioSciences, LLC and n3D Aim to Help Bring Stem Cell Treatments to Market Faster
March 19, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NOKOMIS, Fla.--(BUSINESS WIRE)--As global demand for innovative new stem-cell therapies grows by the day, Rainbow BioSciences’ (OTCBB:RBCC) new agreement with n3D Biosciences could help to bring these therapies to market faster than ever before.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Layoff Tracker
Allogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs
May 16, 2025
·
207 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
BioMarin Expands Enzyme Expertise With $270M Inozyme Buy
May 16, 2025
·
2 min read
·
Tristan Manalac
RNA editing
Lilly Makes $1.3B RNA Editing Bet With Rznomics to Build Out Hearing Loss Pipeline
May 16, 2025
·
2 min read
·
Tristan Manalac
C-suite
UPDATED: With Novo CEO’s Sudden Exit, Analysts Worry ‘There’s Something Pretty Wrong Here’
May 16, 2025
·
5 min read
·
Annalee Armstrong